Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond

Purpose: Radiotherapy is integral in the management of hematological malignancies (HM). Standard radiotherapy dose fractionation regimens range between 20 and 50 Gy in 10–25 fractions over 2–5 weeks. This study presents the outcomes of patients with HM treated with hypofractionation radiotherapy (HF...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Febin Antony, Arbind Dubey, Pamela Skrabek, Lung Fung Tsang, Pascal Lambert, Bohdan Bybel, Naseer Ahmed
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-01-01
Colecção:	Current Oncology
Assuntos:	lymphomas hypofractionation radiotherapy
Acesso em linha:	https://www.mdpi.com/1718-7729/31/1/25
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!